This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

MLex Press Round-Up 20.09.2010

( September 20, 2010, 07:31 GMT | Press Round-Up Europe) -- Contents: Johnson & Johnson in talks to buy Crucell; Mercedes boss named in UK criminal antitrust probe; US tech firms near settlement in hiring probe; EC hints at minor changes to antitrust proceedings; French panel recommends antitrust sanction overhaul; Hochtief rejects ACS bid; EC extends Unilever, Sara Lee merger probe; UK banking panel to probe sector; French panel seeks consensus on banking fees; HRE critised for bonuses in wake of bailout; LSE in talks for London-based clearinghouse; Northern Rock to sell mortgage portfolios; Caisse des Depots to buy into La Poste; Safran plans L-1 purchase; CVC to buy TDC's Swiss mobile unit; Canal+ may face film levy hike; French telcos face contract-mobility measures; EC mulls leeway for French rail liberalisation.- US health care company Johnson & Johnson is negotiations to pay 1.75 billion euros to buy Dutch vaccine maker Crucell....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login